A landmark systematic review has demonstrated that teleretinal screening represents a transformative approach to detecting cytomegalovirus retinitis (CMVR) in people living with HIV, achieving over 95% overall diagnostic accuracy. This finding is particularly significant for resource-limited settings where access to specialized ophthalmological care remains critically scarce.
Cytomegalovirus retinitis disproportionately affects HIV patients with severely compromised immune systems, particularly those with CD4 cell counts below 50 cells/μL. Traditional diagnosis requires direct examination by ophthalmologists, a resource unavailable in many healthcare systems serving vulnerable HIV populations. The meta-analysis, analyzing data from 1,460 eyes across five studies, provides robust evidence that teleretinal screening can effectively bridge this diagnostic gap.
By enabling remote screening capabilities, this technology offers a scalable solution that could prevent thousands of cases of preventable blindness in underserved regions worldwide.
Was this article helpful?
